ALYMSYS vs GLEOSTINE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 9, 2026·How we rate

Possible drug interaction. ALYMSYS and GLEOSTINE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	ALYMSYS	GLEOSTINE
Rating	72/100	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	BEVACIZUMAB-MALY	LOMUSTINE
Manufacturer	Amneal	Azurity
Dosage forms	Injectable	Capsule
Drug class	—	Alkylating Drug
Boxed warning	None	Boxed warning
Half-life	—	about 16 to 48 hours — but note this is the half-life of lomustine's metabolites, not the parent drug
Treats	Non-Small-Cell Lung Carcinoma, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms	Brain Neoplasms, Colonic Neoplasms, Hodgkin Disease

alymsys gleostine

Rating

72/100

Pharmacy pays

—

Type

Active ingredient

BEVACIZUMAB-MALY

LOMUSTINE

Manufacturer

Amneal

Azurity

Dosage forms

Injectable

Capsule

Drug class

—

Alkylating Drug

Boxed warning

None

Boxed warning

Half-life

—

about 16 to 48 hours — but note this is the half-life of lomustine's metabolites, not the parent drug

Treats

Non-Small-Cell Lung Carcinoma, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms

Brain Neoplasms, Colonic Neoplasms, Hodgkin Disease

Frequently asked questions

Which is better-rated, Alymsys or Gleostine?

Alymsys and Gleostine are tied at 3.6 out of 5 by our independent rating.

What is the difference between Alymsys and Gleostine?

Alymsys contains Bevacizumab-Maly, while Gleostine contains Lomustine — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.